CD70-Targeting CAR NK Cells Overcome BCMA Downregulation and Improve Survival in High-risk Multiple Myeloma Models

We demonstrate that CD70 expression is elevated in patients with high-risk multiple myeloma and in patients with t(4;14) translocation. CD70-targeting CAR NK cells exhibit potent cytotoxicity against CD70+ multiple myeloma cells and significantly improve survival in xenograft mouse models of multiple myeloma, even in the absence of BCMA expression. See related commentary by Benson Jr and Caligiuri, p. 166.

Authors

Institutions

Publication Details

Journal
Blood Cancer Discovery
Published
2025-10-27
DOI
https://doi.org/10.1158/2643-3230.bcd-25-0130
Citations
1
Primary Topic
Immune Cell Function and Interaction
Type
article
Field-Weighted Citation Impact
0.80

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CD70-Targeting CAR NK Cells Overcome BCMA Downregulation and Improve Survival in High-risk Multiple Myeloma Models

Ana Karen Nunez Cortes, Luz Yurany Moreno Rueda, Luciana Melo Garcia, Katayoun Rezvani et al.
1 citations
Blood Cancer Discovery
Immune Cell Function and Interaction
0.80
article

CD70-Targeting CAR NK Cells Overcome BCMA Downregulation and Improve Survival in High-risk Multiple Myeloma Models

Ana Karen Nunez Cortes, Luz Yurany Moreno Rueda, Luciana Melo Garcia, Katayoun Rezvani, Nadima Uprety, Gary Deyter, Luis Muniz-Feliciano, Muzaffar H. Qazilbash, Sunil Acharya, Corry M. Jones, April L. Gilbert, Rafet Başar, Seema Rawal, David Marín, Robert Zygmunt Orlowski, Pinaki P. Banerjee, Hans Chulhee Lee, Richard E. Champlin, Vernikka Woods, Elizabeth J. Shpall, Rejeena Shrestha, Krina K. Patel, May Daher, Paul Lin, Dexing Fang, Francia Reyes-Silva, Chenyu Zhang, Ping Li, Pei Lin
article en
1 citations

Abstract

We demonstrate that CD70 expression is elevated in patients with high-risk multiple myeloma and in patients with t(4;14) translocation. CD70-targeting CAR NK cells exhibit potent cytotoxicity against CD70+ multiple myeloma cells and significantly improve survival in xenograft mouse models of multiple myeloma, even in the absence of BCMA expression. See related commentary by Benson Jr and Caligiuri, p. 166.

Blood Cancer DiscoveryVol. 7(2)
The University of Texas MD Anderson Cancer Center (US), Baylor College of Medicine (US), Université Laval (CA)
Conquer Cancer Foundation, Multiple Myeloma Research Foundation, Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, American Society of Clinical Oncology, Johns Hopkins University, National Institutes of Health, University of Texas MD Anderson Cancer Center
Openalex Percentile: Top 22%
Immune Cell Function and Interaction
0.80
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.